Healthcare consumers have a new tool to compare prices using data from some of the largest U.S. health insurers, but comparison shopping will remain a challenge for most.
Two health insurers already operating in Iowa have indicated they will bid on Iowa's new proposal to outsource its $4.2 billion Medicaid program to managed-care companies. It's the latest state move to privatize the health insurance program for low-income Americans.
Paula Ercolini is one of about 1.8 million seniors who are part of a Medicare Advantage advocacy group that is blitzing the airwaves and putting pressure on the Obama administration and Congress.
Dr. J. Mario Molina, chairman and CEO of Molina Healthcare, discusses how he and his family developed the company, the mission of serving Medicaid patients, his prediction on what happens if the U.S. Supreme Court strikes down premium subsidies, and Molina's M&A strategies.
Aetna recorded more than $2 billion in profit in fiscal 2014, the highest level in the company’s history and a signal that healthcare reform continues to treat the health insurance industry well.
Even as value-based contracting proliferates, the financial incentives for hospitals and medical groups to eliminate waste and improve care have barely changed.
U.S. healthcare providers and insurers start from widely divergent places as some of the largest move to put most of their business into payment models that reward lower cost and higher quality care.
Several of the nation's largest health systems and insurers are joining together in a new task force with the goal of shifting 75% of their business to contracts with incentives for quality and lower-cost healthcare.
The Iowa Insurance Division said Friday that not-for-profit health insurer CoOportunity Health could not be saved and ordered its liquidation by the end of February.
A growing number of Americans are expected to need long-term-care services such as nursing home and home health care in the coming years. But experts increasingly doubt that private LTC insurance alone is a viable way to finance that care.
Top healthcare executives who gathered in San Francisco this past week at the J.P. Morgan Healthcare Conference widely agreed that the healthcare reform law's coverage expansion and other provisions are not in jeopardy at the hands of congressional Republicans or the Supreme Court. Really?
Aetna has agreed to a deal with Gilead Sciences to give preference to the drugmaker's hepatitis C drugs. It's the fourth straight agreement where a payer or benefits manager has chosen Gilead over competitor AbbVie.